MS Compass: Guiding Clinical Care, a podcast hosted by neuroimmunologist Lindsay Ross, MD, brings you an exclusive interview with Rachel Galioto, PhD. [LISTEN TIME: 33 minutes]
|Videos|November 3, 2020
Webinar: Differing Perspectives on Multiple Sclerosis Nursing Care: Patient Program
Author(s)NeurologyLive® Staff
A 2-part webcast series geared toward MS nursing professionals and patients.
Advertisement
This webcast features presentations by Denise Bruen, ANP-BC, MSN, MSCN; Stephanie Agrella, PhDc, MSN, RN, ANP-BC, MSCN; and Marie Namey, APRN, MSCN. This innovative program provides patients with evidence-based information on the latest disease-modifying therapies, as well as symptoms and the psychological impact of MS, in order to educate and improve the relationships between MS nursing professionals and their patients.
If you are an MS nursing professional,
Advertisement
Related to this article
The positive opinion for intravenous ocrelizumab was supported by phase 3 OPERETTA 2 findings demonstrating noninferior relapse control and superior suppression of MRI-detected brain lesions compared with fingolimod in pediatric patients with relapsing MS.
An ACT–based group intervention did not significantly improve resilience at 3 months in patients with MS but was associated with improvements in anxiety, well-being, psychological flexibility, and health-related quality of life.
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 18, 2026.
Brian Lin, PhD, discussed the current evidence linking football participation with ALS, the questions that remain unanswered, and how emerging research may help clarify the association.
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Jennifer Fokas, MD, and Minali Nigam, MD. [LISTEN TIME: 21 minutes]
A recent MS cohort study suggests that higher EBV nuclear antigen 1 antibody levels are associated with a lower risk of confirmed disability worsening, particularly among patients carrying both HLA-A02:01 and HLA-DRB115:01.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
What's Next in Ataxia: Pipeline Overview of Investigational Therapeutics
2
FDA Grants Fast Track Designation to Apitegromab for Facioscapulohumeral Muscular Dystrophy
3
Azetukalner NDA Submitted, EMA Gives Approval Recommendation to Ocrelizumab, Phase 3 FUSION Trial Meets End Points
4
SKY-0515 Shows Sustained Benefit at 15 Months in Huntington Disease
5